New medicines that spur weight loss and treat diabetes have been having the public—plus the pharmaceutical industry—by storm. The most up-to-date entrant, Zepbound, just lately joined Ozempic, Wegovy, Victoza and others in a growing course of drugs known as GLP-1 receptor agonists.have severe challenges with your tummy, for instance slowed empt